Brief: Eledon Pharmaceuticals Reports Second Quarter 2022 Operating And Financial Results
11/08/2022 21:21
Aug 11 (Reuters) - Eledon Pharmaceuticals Inc ELDN.O :
* ELEDON PHARMACEUTICALS REPORTS SECOND QUARTER 2022
OPERATING AND
FINANCIAL RESULTS
* BELIEVES THAT IT HAS SUFFICIENT FINANCIAL RESOURCES TO
FUND
OPERATING ACTIVITIES INTO 2024
* ELEDON PHARMA - HAD ABOUT $70.5 MILLION IN CASH & CASH
EQUIVALENTS AS OF JUNE 30, 2022, VERSUS $84.8 MILLION IN CASH
AND CASH EQUIVALENTS AS OF DEC 31, 2021
* QTRLY LOSS PER SHARE $0.65
* Q2 EARNINGS PER SHARE VIEW $-0.70 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNXc0jXkB
Further company coverage: ELDN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eledon Pharmaceuticals
See all newsBrief: Eledon Presents Updated Long-Term Phase 2 Bestow Extension Study Results At The International Congress Of The Transplantation Society
Eledon Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Eledon Pharmaceuticals Q2 net loss widens on warrant liability changes
Eledon Pharmaceuticals Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: Natera And Eledon Announce Strategic Partnership For Prospera™ Monitoring In Planned Phase 3 Kidney Transplant Trial